See more : Getabec Public Company Limited (GTB.BK) Income Statement Analysis – Financial Results
Complete financial analysis of Mirion Technologies, Inc. (MIR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Mirion Technologies, Inc., a leading company in the Industrial – Machinery industry within the Industrials sector.
- CVRx, Inc. (CVRX) Income Statement Analysis – Financial Results
- Morgan Advanced Materials plc (MGAM.L) Income Statement Analysis – Financial Results
- Chipotle Mexican Grill, Inc. (CMG) Income Statement Analysis – Financial Results
- Ikka Holdings Co.,Ltd. (7127.T) Income Statement Analysis – Financial Results
- 99 Acquisition Group Inc. Right (NNAGR) Income Statement Analysis – Financial Results
Mirion Technologies, Inc. (MIR)
About Mirion Technologies, Inc.
Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, and Japan. It operates through two segments, Medical and Industrial. The medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture, and rehabilitation products. This segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation. The Industrial segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include nuclear medicines, dosimeters, contamination and clearance monitors, reactor instrumentation and control equipment and systems, medical and industrial imaging systems and related accessories, alpha spectroscopy instruments, alpha/beta counting instruments, and gamma spectroscopy detector systems; and electrical penetration, cancer diagnostics, software, and other services. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. Mirion Technologies, Inc. was incorporated in 2005 and is headquartered in Atlanta, Georgia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 800.90M | 717.80M | 322.10M | 478.20M | 440.10M | 444.10M |
| Cost of Revenue | 444.50M | 400.60M | 241.00M | 281.20M | 251.80M | 275.70M |
| Gross Profit | 356.40M | 317.20M | 81.10M | 197.00M | 188.30M | 168.40M |
| Gross Profit Ratio | 44.50% | 44.19% | 25.18% | 41.20% | 42.79% | 37.92% |
| Research & Development | 31.70M | 30.30M | 17.00M | 15.90M | 14.00M | 19.30M |
| General & Administrative | 337.30M | 355.40M | 124.90M | 1.37M | 341.00 | -599.71K |
| Selling & Marketing | 1.30M | 1.70M | 800.00K | 900.00K | 800.00K | 600.00K |
| SG&A | 340.10M | 357.10M | 125.70M | 1.37M | 341.00 | 295.00 |
| Other Expenses | 6.50M | 5.20M | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 378.30M | 392.60M | 142.70M | 1.37M | 341.00 | 295.00 |
| Cost & Expenses | 822.80M | -181.30M | 383.70M | 1.37M | 341.00 | 295.00 |
| Interest Income | 4.80M | 41.90M | 145.80M | 149.20M | 143.50M | 128.90M |
| Interest Expense | 61.90M | 42.50M | 59.00M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 162.80M | 173.90M | 62.90M | 68.40M | 69.50M | 77.00M |
| EBITDA | 114.30M | -90.80M | -19.20M | 22.88M | 98.40M | 72.30M |
| EBITDA Ratio | 14.27% | 14.53% | 0.40% | -0.30% | 0.00% | 0.00% |
| Operating Income | -21.90M | 266.90M | -61.60M | -1.37M | -341.00 | -300.00 |
| Operating Income Ratio | -2.73% | 37.18% | -19.12% | -0.29% | 0.00% | 0.00% |
| Total Other Income/Expenses | -83.40M | -8.80M | -72.40M | -24.31M | -28.80M | 4.70M |
| Income Before Tax | -105.30M | -306.60M | -141.10M | -1.31M | -341.00 | -295.00 |
| Income Before Tax Ratio | -13.15% | -42.71% | -43.81% | -0.27% | 0.00% | 0.00% |
| Income Tax Expense | -6.60M | 18.20M | -12.40M | -265.90K | 4.20M | 36.80M |
| Net Income | -96.90M | -324.80M | -127.90M | -1.04M | -341.00 | -295.00 |
| Net Income Ratio | -12.10% | -45.25% | -39.71% | -0.22% | 0.00% | 0.00% |
| EPS | -0.49 | -1.79 | -0.61 | -0.02 | 0.00 | 0.00 |
| EPS Diluted | -0.49 | -1.79 | -0.61 | -0.02 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 196.37M | 181.15M | 208.08M | 56.99M | 20.13M | 95.13M |
| Weighted Avg Shares Out (Dil) | 196.37M | 181.15M | 208.08M | 56.99M | 20.13M | 95.13M |
Mirion Announces Departure of Medical Group President
Mirion Announces Earnings Release and Conference Call Date for Third Quarter 2023
Mirion Technologies Gamma Detector to Play Crucial Role in NASA's Psyche Mission
Sun Nuclear® Solutions Supporting Better Patient Care in Focus at ASTRO 2023
Sun Nuclear SunSCAN™ 3D Water Scanning System Receives CE Marking
Mirion to Present at the Jefferies Industrials Conference
Mirion Technologies: Wait When The Targets Are Met
Mirion Technologies Awarded Strategic Design Contract for X-energy's Small Modular Reactor
Mirion Technologies, Inc. (MIR) Q2 2023 Earnings Call Transcript
Mirion Announces Second Quarter 2023 Financial Results and Updates Full Year Guidance
Source: https://incomestatements.info
Category: Stock Reports